{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T17:14:15Z","timestamp":1788369255149,"version":"build-2803163510"},"reference-count":22,"publisher":"American Association for Cancer Research (AACR)","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","award":["137515"],"award-info":[{"award-number":["137515"]}],"id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Fatigue is a common and often debilitating adverse event among patients receiving immune checkpoint inhibitor (ICI) therapy, yet its underlying immunologic mechanisms remain poorly defined. We prospectively collected clinical data and blood samples from patients with solid tumors receiving ICI therapy. Patients were prospectively surveyed at month 2, 4, or 6 on treatment to assess for the presence and severity of fatigue as compared with treatment baseline. We analyzed peripheral lymphocyte populations by cytometry by time of flight and peripheral levels of 39 cytokines with a Luminex multiplex assay to identify dynamic immune changes associated with ICI-related fatigue. Of 53 patients enrolled, 31 (58.5%) reported worsening fatigue during ICI therapy. Patients reporting fatigue exhibited broad early-treatment elevations in circulating cytokines, with the most prominent increases observed in the Th1-associated cytokine cluster, including IFN-\u03b3, IL-2, and IL-12. In parallel, several clusters of cytotoxic effector CD8+ T cells expanded significantly from baseline in the fatigued group. Fatigue was not associated with objective tumor response or with the development of other clinically meaningful immune-related adverse events. In a pan-tumor cohort treated with ICIs, increases in clusters of cytotoxic effector CD8+ T cells in parallel with related Th1-associated cytokines were associated with ICI-related fatigue, implicating fatigue as a potential marker of immune activation in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>This study illuminates dynamic changes in peripheral cytokines and immune cell clusters that are associated with ICI-related fatigue. Namely, this study implicates the Th1 pathway as a novel contributor to ICI-related fatigue and identifies ICI-related fatigue as a clinical surrogate for immune activation in patients receiving ICI therapy. Recognizing that fatigue may be a biomarker of heightened immune activity influences monitoring strategies and informs supportive care interventions during immunotherapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-25-0240","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T14:40:52Z","timestamp":1757947252000},"page":"1738-1746","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Immune Activation Signatures Associated with Fatigue in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy"],"prefix":"10.1158","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2223-5444","authenticated-orcid":false,"given":"Howard L.","family":"Li","sequence":"first","affiliation":[{"name":"1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland."},{"name":"2Convergence Institute, Johns Hopkins University, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9148-9870","authenticated-orcid":false,"given":"Soren","family":"Charmsaz","sequence":"additional","affiliation":[{"name":"1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland."},{"name":"2Convergence Institute, Johns Hopkins University, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6055-8960","authenticated-orcid":false,"given":"Mari","family":"Nakazawa","sequence":"additional","affiliation":[{"name":"1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland."},{"name":"2Convergence Institute, Johns Hopkins University, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0500-8696","authenticated-orcid":false,"given":"Stephanie L.","family":"Alden","sequence":"additional","affiliation":[{"name":"1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2401-3694","authenticated-orcid":false,"given":"Madelena","family":"Brancati","sequence":"additional","affiliation":[{"name":"1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1721-2128","authenticated-orcid":false,"given":"James M.","family":"Leatherman","sequence":"additional","affiliation":[{"name":"1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland."},{"name":"2Convergence Institute, Johns Hopkins University, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7368-1561","authenticated-orcid":false,"given":"Ervin","family":"Griffin","sequence":"additional","affiliation":[{"name":"1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland."},{"name":"2Convergence Institute, Johns Hopkins University, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8388-6297","authenticated-orcid":false,"given":"Hua-Ling","family":"Tsai","sequence":"additional","affiliation":[{"name":"1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8936-207X","authenticated-orcid":false,"given":"Nicole E.","family":"Gross","sequence":"additional","affiliation":[{"name":"1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland."},{"name":"2Convergence Institute, Johns Hopkins University, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7743-9183","authenticated-orcid":false,"given":"Christopher J.","family":"Thoburn","sequence":"additional","affiliation":[{"name":"1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6044-2631","authenticated-orcid":false,"given":"Alexei","family":"Hernandez","sequence":"additional","affiliation":[{"name":"1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0393-6600","authenticated-orcid":false,"given":"Erin M.","family":"Coyne","sequence":"additional","affiliation":[{"name":"1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7658-5899","authenticated-orcid":false,"given":"Sarah M.","family":"Shin","sequence":"additional","affiliation":[{"name":"1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7771-3208","authenticated-orcid":false,"given":"Royce P.","family":"Lee","sequence":"additional","affiliation":[{"name":"1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2976-0911","authenticated-orcid":false,"given":"Evan J.","family":"Lipson","sequence":"additional","affiliation":[{"name":"1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland."},{"name":"3Bloomberg\u223cKimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7180-8790","authenticated-orcid":false,"suffix":"III","given":"Burles A.","family":"Johnson","sequence":"additional","affiliation":[{"name":"1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7605-8497","authenticated-orcid":false,"given":"Aliyah","family":"Pabani","sequence":"additional","affiliation":[{"name":"1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6671-7002","authenticated-orcid":false,"given":"Yasser","family":"Ged","sequence":"additional","affiliation":[{"name":"1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0125-2405","authenticated-orcid":false,"given":"Marina","family":"Baretti","sequence":"additional","affiliation":[{"name":"1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2443-8395","authenticated-orcid":false,"given":"Julie R.","family":"Brahmer","sequence":"additional","affiliation":[{"name":"1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland."},{"name":"3Bloomberg\u223cKimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6970-6509","authenticated-orcid":false,"given":"Jean","family":"Hoffman-Censits","sequence":"additional","affiliation":[{"name":"1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7919-8272","authenticated-orcid":false,"given":"Tanguy Y.","family":"Seiwert","sequence":"additional","affiliation":[{"name":"1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8184-3346","authenticated-orcid":false,"given":"Daniel J.","family":"Zabransky","sequence":"additional","affiliation":[{"name":"1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland."},{"name":"2Convergence Institute, Johns Hopkins University, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9097-9125","authenticated-orcid":false,"given":"Jennifer N.","family":"Durham","sequence":"additional","affiliation":[{"name":"1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland."},{"name":"2Convergence Institute, Johns Hopkins University, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3841-6549","authenticated-orcid":false,"given":"Elizabeth M.","family":"Jaffee","sequence":"additional","affiliation":[{"name":"1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland."},{"name":"2Convergence Institute, Johns Hopkins University, Baltimore, Maryland."},{"name":"3Bloomberg\u223cKimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5339-9906","authenticated-orcid":false,"given":"G. Scott","family":"Chandler","sequence":"additional","affiliation":[{"name":"4F. Hoffmann-La Roche Ltd., a member of the imCORE network, Basel, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9912-2435","authenticated-orcid":false,"given":"Brittany L.","family":"Adler","sequence":"additional","affiliation":[{"name":"5Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2644-5086","authenticated-orcid":false,"given":"Won Jin","family":"Ho","sequence":"additional","affiliation":[{"name":"1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland."},{"name":"2Convergence Institute, Johns Hopkins University, Baltimore, Maryland."},{"name":"3Bloomberg\u223cKimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2568-2071","authenticated-orcid":false,"given":"Chester","family":"Kao","sequence":"additional","affiliation":[{"name":"1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4401-0748","authenticated-orcid":false,"given":"Mark","family":"Yarchoan","sequence":"additional","affiliation":[{"name":"1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, a member of the imCORE network, Baltimore, Maryland."},{"name":"2Convergence Institute, Johns Hopkins University, Baltimore, Maryland."},{"name":"3Bloomberg\u223cKimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"2025100103414718600_bib1","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.3390\/curroncol29050247","article-title":"Immune checkpoint inhibitors in cancer therapy","volume":"29","author":"Shiravand","year":"2022","journal-title":"Curr Oncol"},{"key":"2025100103414718600_bib2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1186\/s12967-019-02132-x","article-title":"Early fatigue in cancer patients receiving PD-1\/PD-L1 checkpoint inhibitors: an insight from clinical practice","volume":"17","author":"Cortellini","year":"2019","journal-title":"J Transl Med"},{"key":"2025100103414718600_bib3","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1002\/cam4.3617","article-title":"A real-world data of Immune checkpoint inhibitors in solid tumors from India","volume":"10","author":"Noronha","year":"2021","journal-title":"Cancer Med"},{"key":"2025100103414718600_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fphar.2017.00049","article-title":"Current diagnosis and management of immune related adverse events (irAEs) induced by immune checkpoint inhibitor therapy","volume":"8","author":"Kumar","year":"2017","journal-title":"Front Pharmacol"},{"key":"2025100103414718600_bib5","doi-asserted-by":"crossref","first-page":"100474","DOI":"10.1016\/j.esmoop.2022.100474","article-title":"Incidence of fatigue associated with immune checkpoint inhibitors in patients with cancer: a meta-analysis","volume":"7","author":"Kiss","year":"2022","journal-title":"ESMO Open"},{"key":"2025100103414718600_bib6","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.12968\/bjon.2021.30.4.S36","article-title":"Cancer-related fatigue: an overview","volume":"30","author":"Al Maqbali","year":"2021","journal-title":"Br J Nurs"},{"key":"2025100103414718600_bib7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jpainsymman.2006.10.012","article-title":"The relationship between cancer-related fatigue and patient satisfaction with quality of life in cancer","volume":"34","author":"Gupta","year":"2007","journal-title":"J Pain Symptom Manage"},{"key":"2025100103414718600_bib8","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrclinonc.2014.127","article-title":"Cancer-related fatigue\u2013mechanisms, risk factors, and treatments","volume":"11","author":"Bower","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"issue":"Suppl 6","key":"2025100103414718600_bib9","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1002\/1097-0142(20010915)92:6+<1684::AID-CNCR1497>3.0.CO;2-Z","article-title":"The role of cytokines in cancer-related fatigue","volume":"92","author":"Kurzrock","year":"2001","journal-title":"Cancer"},{"key":"2025100103414718600_bib10","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1200\/JCO.2012.46.2143","article-title":"Cytokine genetic variations and fatigue among patients with breast cancer","volume":"31","author":"Bower","year":"2013","journal-title":"J Clin Oncol"},{"key":"2025100103414718600_bib11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1749-6632.2001.tb05824.x","article-title":"Cytokines and chronic fatigue syndrome","volume":"933","author":"Patarca","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"2025100103414718600_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40425-018-0343-9","article-title":"Cytokine release syndrome","volume":"6","author":"Shimabukuro-Vornhagen","year":"2018","journal-title":"J Immunother Cancer"},{"key":"2025100103414718600_bib13","doi-asserted-by":"crossref","first-page":"719","DOI":"10.18632\/oncotarget.27946","article-title":"Immunotherapy and fatigue: what we know and what we don\u2019t know","volume":"12","author":"Azeem Khan","year":"2021","journal-title":"Oncotarget"},{"key":"2025100103414718600_bib14","doi-asserted-by":"crossref","first-page":"e176567","DOI":"10.1172\/JCI176567","article-title":"Immune-related events in individuals with solid tumors on immunotherapy associate with Th17 and Th2 signatures","volume":"134","author":"Kao","year":"2024","journal-title":"J Clin Invest"},{"key":"2025100103414718600_bib15","doi-asserted-by":"crossref","first-page":"e009734","DOI":"10.1136\/jitc-2024-009734","article-title":"Pan-tumor analysis to investigate the obesity paradox in immune checkpoint blockade","volume":"13","author":"Alden","year":"2025","journal-title":"J Immunother Cancer"},{"key":"2025100103414718600_bib16","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1158\/2326-6066.CIR-24-1055","article-title":"Anti-CTLA4 therapy leads to early expansion of a peripheral Th17 population and induction of Th1 cytokines","volume":"13","author":"Nakazawa","year":"2025","journal-title":"Cancer Immunol Res"},{"key":"2025100103414718600_bib17","doi-asserted-by":"crossref","first-page":"eadi9379","DOI":"10.1126\/sciadv.adi9379","article-title":"Spontaneous, persistent, T cell\u2013dependent IFN-\u03b3 release in patients who progress to Long Covid","volume":"10","author":"Krishna","year":"2024","journal-title":"Sci Adv"},{"key":"2025100103414718600_bib18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1359-6101(01)00038-7","article-title":"The roles of IFN gamma in protection against tumor development and cancer immunoediting","volume":"13","author":"Ikeda","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"issue":"Suppl 11","key":"2025100103414718600_bib19","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1200\/OP.2023.19.11_suppl.294","article-title":"Fatigue in patients with cancer treated on immunotherapy-based early phase clinical trials","volume":"19","author":"Ahmed","year":"2023","journal-title":"JCO Oncol Pract"},{"key":"2025100103414718600_bib20","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1007\/s00432-022-04205-9","article-title":"Non-specific symptoms as a prodrome of immune-related adverse events in patients with non-small cell lung cancer receiving nivolumab: a consecutive analysis of 200 patients","volume":"149","author":"Higashiyama","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"2025100103414718600_bib21","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1158\/2326-6066.CIR-17-0208","article-title":"Characterization of thyroid disorders in patients receiving immune checkpoint inhibition therapy","volume":"5","author":"Lee","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"2025100103414718600_bib22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/jama.2021.6036","article-title":"Immune checkpoint inhibitor therapy toxicities-reply","volume":"326","author":"Cifu","year":"2021","journal-title":"JAMA"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-25-0240\/3650977\/crc-25-0240.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/10\/1738\/3656923\/crc-25-0240.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/10\/1738\/3656923\/crc-25-0240.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T07:41:56Z","timestamp":1759304516000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/5\/10\/1738\/766017\/Immune-Activation-Signatures-Associated-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-25-0240","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.30256029","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30256017","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30256038","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30256026","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30256050","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30256014","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30256047","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30256035","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30256023","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30256011","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30256044","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30256032","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30256053","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30256020","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30256041","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.8065224","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]}}}